Aerie Pharmaceuticals, Inc. - stock earnings
Stock symbol AERI is outdated, potentially delisted? Maybe it is available on other exchange?
AERI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -26.8 million USD | 36.1 million USD |
| 2022Q2 | -19.4 million USD | 33.3 million USD |
| 2022Q1 | -35.9 million USD | 29.8 million USD |
| 2021Q4 | 45.5 million USD | 114.7 million USD |
| 2021Q3 | -39.7 million USD | 29.3 million USD |
| 2021Q2 | -38.7 million USD | 27.2 million USD |
| 2021Q1 | -42.0 million USD | 23.0 million USD |
| 2020Q4 | -46.1 million USD | 24.7 million USD |
| 2020Q3 | -39.6 million USD | 20.1 million USD |
AERI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -74.8 million USD | 194.1 million USD |
| 2020 | -183.1 million USD | 83.1 million USD |
| 2019 | -199.6 million USD | 69.9 million USD |
| 2018 | -232.6 million USD | 24.2 million USD |
| 2017 | -145.1 million USD | ? USD |
AERI
Price: $15.25
52 week price:
Earnings Per Share: -1.03 USD
P/E Ratio: -3.28
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 591810
Ebitda: -31.4 millionMarket Capitalization: 752.6 million